Skin CD30+ T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease-Reference-Cited by-同舟云学术

Skin CD30+ T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease

Published:2013-08-31 Issue:1 Volume:5 Page:21-26
ISSN:2038-0305
Container-title:Autoimmunity Highlights
language:en
Short-container-title:Autoimmun Highlights

Author:

Amedei Amedeo,Pimpinelli Nicola,Grassi Alessia,Bella Chiara Della,Niccolai Elena,Brancati Simona,Benagiano Marisa,D’Elios Sofia,Bosi Alberto,D’Elios Mario M.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Rheumatology

Link

http://link.springer.com/article/10.1007/s13317-013-0054-7/fulltext.html

Reference18 articles.

1. Greenblatt MB, Aliprantis AO (2013) The immune pathogenesis of scleroderma: context is everything. Curr Rheumatol Rep 15:297

2. Yamamoto T (2010) Animal model of systemic sclerosis. J Dermatol 37:26–41

3. Artlett CM (2010) Animal models of scleroderma: fresh insights. Curr Opin Rheumatol 22:677–682

4. Jaffee BD, Claman HN (1983) Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol 77:1–12

5. Fleming JN, Shulman HM, Nash RA, Johnson PY, Wight TN, Gown A, Schwartz SM (2009) Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis. PLoS ONE 4:e6203

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis;Pharmaceuticals;2023-07-27

2. T-Cell Costimulation and Coinhibition in Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect;Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation;2019

3. Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents;Expert Opinion on Biological Therapy;2016-02-06